WEBCAST: Click HERE to view the presentations from this forum

This leading international forum annually attracts over 500 delegates from the USA and overseas representing both listed and private biotech companies, corporate and financial investors and their advisers. Delegates can attend corporate, analyst and investor panels and listen to streamed presentations of about 60 companies over two days. The forum is highly regarded as transactional and presenting companies and speakers are generally available for one to one meetings arranged in advance through Sachs Associates’ online one to one meeting system.

The forum is an excellent platform for emerging growth and established biotech companies from the US and overseas to address investors, their advisers and media. Every year around 60 are selected to present, with listed companies presenting on the first day. The private companies, which are mostly IPO prospects and venture-funded are streamed by sector. Workshop sectors cover Therapeutics, Immunology/Oncology, Post Genomics and Cardiovascular.

The program provides roundtables on key industry and scientific developments as well as finance and investment trends and will include a segment focused specifically on scientific presentations from industry experts in the oncology and cardiovascular fields.

DAY ONE
• Keynote State of the Industry Update with previously unreleased data
• Roundtable panels with leading analysts and investors
• Presentations by listed and unlisted companies

DAY TWO
• Bio-pharma practical guide to alliances
• Science focussed Oncology Panel
• Company presentations

An allocation of complimentary places is available for qualified institutional investors, analysts and fund managers. To apply for a complimentary place please contact Yulia Hayward on + 44 20 7405 5544 or email yulia@sachsforum.com

For sponsorship, speaking, presenting, partnering & exhibiting opportunities email Hannah-Louise Stewart on + 44 20 7405 5544 or email hl@sachsform.com

Boston is a pre-eminent centre for biotech companies and the money management community. The event has been supported by leading community professional organizations including Mass Bio and the tech transfer session has the participation of Harvard University and the Medical Schools, MIT and Whitehead and attracts scientists connected with the major academic and industry research facilities in the area.